Y, I., N, O., M, M., Y, N., Y, S., & S, Y. (2026). Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer. Pharmacoepidemiology and drug safety, 35(9), e70478. https://doi.org/10.1002/pds.70478
Παραπομπή σε μορφή Chicago (17η εκδ.)Y, Ihara, Okada N, Mizutani M, Nakamura Y, Shimomura Y, και Yamamoto S. "Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer." Pharmacoepidemiology and Drug Safety 35, no. 9 (2026): e70478. https://doi.org/10.1002/pds.70478.
Παραπομπή σε μορφή MLA (9th εκδ.)Y, Ihara, et al. "Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer." Pharmacoepidemiology and Drug Safety, vol. 35, no. 9, 2026, p. e70478, https://doi.org/10.1002/pds.70478.